Published Date: 02 Mar 2023
A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .
Read Full NewsWomen living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.
3.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
A garden can save your life
1.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
2.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
3.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
4.
A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer
5.
Exploring the Normal Range of Monocytes: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation